MicroRNA and colorectal cancer

Digestive and Liver Disease

Volumn 44, Issue 3, 2012, Pages 195-200

  Corté, Hélène ^a,b   Manceau, Gilles ^a,b   Blons, Hélène ^a,b   Laurent Puig, Pierre ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSERM   (France)

Author keywords

Biomarker; Carcinogenesis; Diagnosis; Prognosis

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 1; MICRORNA 101; MICRORNA 106A; MICRORNA 125A; MICRORNA 126; MICRORNA 130B; MICRORNA 133A; MICRORNA 17; MICRORNA 18A; MICRORNA 19A; MICRORNA 19B; MICRORNA 20; MICRORNA 20A; MICRORNA 21; MICRORNA 25; MICRORNA 29A; MICRORNA 30A; MICRORNA 30C; MICRORNA 31; MICRORNA 32; MICRORNA 33A; MICRORNA 34A; MICRORNA 7; MICRORNA 92A; MICRORNA 93; MICRORNA 95; MICRORNA 96; UNCLASSIFIED DRUG; UNINDEXED DRUG;

CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER STAGING; COLORECTAL CANCER; DOWN REGULATION; DRUG RESPONSE; HUMAN; PREDICTION; PRIORITY JOURNAL; REVIEW; TREATMENT RESPONSE;

COLORECTAL NEOPLASMS; FECES; HUMANS; MICRORNAS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84856568164     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2011.10.010     Document Type: Review

References (48)

1. Lothe R.A., Peltomaki P., Meling G.I., et al. Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res 1993, 53:5849-5852.
2. Calin G.A., Sevignani C., Dumitru C.D., et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 2004, 101:2999-3004.
3. Lawrie C.H., Gal S., Dunlop H.M., et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 2008, 141:672-675.
4. Wong T.S., Liu X.B., Wong B.Y., et al. Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res 2008, 14:2588-2592.
5. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
6. Krol J., Loedige I., Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010, 11:597-610.
7. Barault L., Veyrie N., Jooste V., et al. Mutations in the RAS-MAPK, PI(3)K (phosphatidylinositol-3-OH kinase) signaling network correlate with poor survival in a population-based series of colon cancers. Int J Cancer 2008, 122:2255-2259.
8. Slattery M.L., Wolff E., Hoffman M.D., et al. MicroRNAs and colon and rectal cancer: differential expression by tumor location and subtype. Genes Chromosomes Cancer 2011, 50:196-206.
9. Schepeler T., Reinert J.T., Ostenfeld M.S., et al. Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res 2008, 68:6416-6424.
10. Earle J.S., Luthra R., Romans A., et al. Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma. J Mol Diagn 2010, 12:433-440.
11. Wu W.K., Law P.T., Lee C.W., et al. MicroRNA in colorectal cancer: from benchtop to bedside. Carcinogenesis 2011, 32:247-253.
12. Akao Y., Nakagawa Y., Hirata I., et al. Role of anti-oncomirs miR-143 and -145 in human colorectal tumors. Cancer Gene Ther 2010, 17:398-408.
13. Slaby O., Svoboda M., Fabian P., et al. Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology 2007, 72:397-402.
14. Wang C.J., Zhou Z.G., Wang L., et al. Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer. Dis Markers 2009, 26:27-34.
15. Akao Y., Nakagawa Y., Naoe T. MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers. Oncol Rep 2006, 16:845-850.
16. Ng E.K., Tsang W.P., Ng S.S., et al. MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. Br J Cancer 2009, 101:699-706.
17. Akao Y., Nakagawa Y., Naoe T. Let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol Pharm Bull 2006, 29:903-906.
18. Ng E.K., Chong W.W., Jin H., et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 2009, 58:1375-1381.
19. Huang Z., Huang D., Ni S., et al. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 2010, 127:118-126.
20. Schetter A.J., Leung S.Y., Sohn J.J., et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. J Am Med Assoc 2008, 299:425-436.
21. Cheng H., Zhang L., Cogdell D.E., et al. Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis. PLoS One 2011, 6:e17745.
22. Nakajima G., Hayashi K., Xi Y., et al. Non-coding MicroRNAs hsa-let-7g and hsa-miR-181b are associated with chemoresponse to S-1 in colon cancer. Cancer Genomics Proteomics 2006, 3:317-324.
23. Graziano F., Canestrari E., Loupakis F., et al. Genetic modulation of the Let-7 microRNA binding to KRAS 3'-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab-irinotecan. Pharmacogenomics J 2010, 10:458-464.
24. Ragusa M., Majorana A., Statello L., et al. Specific alterations of microRNA transcriptome and global network structure in colorectal carcinoma after cetuximab treatment. Mol Cancer Ther 2010, 9:3396-3409.
25. Kulda V., Pesta M., Topolcan O., et al. Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases. Cancer Genet Cytogenet 2010, 200:154-160.
26. Michael M.Z., van S.M.O.C., Holst Pellekaan N.G., et al. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 2003, 1:882-891.
27. Chen X., Guo X., Zhang H., et al. Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene 2009, 28:1385-1392.
28. Chim S.S., Shing T.K., Hung E.C., et al. Detection and characterization of placental microRNAs in maternal plasma. Clin Chem 2008, 54:482-490.
29. Mitchell P.S., Parkin R.K., Kroh E.M., et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008, 105:10513-10518.
30. Pu X.X., Huang G.L., Guo H.Q., et al. Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression. J Gastroenterol Hepatol 2010, 25:1674-1680.
31. Ahmed F.E., Jeffries C.D., Vos P.W., et al. Diagnostic microRNA markers for screening sporadic human colon cancer and active ulcerative colitis in stool and tissue. Cancer Genomics Proteomics 2009, 6:281-295.
32. Koga Y., Yasunaga M., Takahashi A., et al. MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening. Cancer Prev Res (Phila) 2010, 3:1435-1442.
33. Link A., Balaguer F., Shen Y., et al. Fecal microRNAs as novel biomarkers for colon cancer screening. Cancer Epidemiol Biomarkers Prev 2010, 19:1766-1774.
34. Hummel R., Hussey D.J., Haier J. MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types. Eur J Cancer 2010, 46:298-311.
35. Lievre A., Bachet J.B., Le Corre D., et al. KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer. Cancer Res 2006, 66:3992-3995.
36. Johnson S.M., Grosshans H., Shingara J., et al. RAS is regulated by the let-7 microRNA family. Cell 2005, 120:635-647.
37. Chin L.J., Ratner E., Leng S., et al. A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. Cancer Res 2008, 68:8535-8540.
38. Zhang W., Winder T., Ning Y., et al. A let-7 microRNA-binding site polymorphism in 3'-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with cetuximab monotherapy. Ann Oncol 2011, 22:104-109.
39. de Krijger I., Mekenkamp L.J., Punt C.J., et al. MicroRNAs in colorectal cancer metastasis. J Pathol 2011, 224:438-447.
40. Cummins J.M., He Y., Leary R.J., et al. The colorectal microRNAome. Proc Natl Acad Sci USA 2006, 103:3687-3692.
41. Sarver A.L., French A.J., Borralho P.M., et al. Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. BMC Cancer 2009, 9:401.
42. Motoyama K., Inoue H., Takatsuno Y., et al. Over- and under-expressed microRNAs in human colorectal cancer. Int J Oncol 2009, 34:1069-1075.
43. Xi Y., Nakajima G., Gavin E., et al. Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. RNA 2007, 13:1668-1674.
44. Arndt G.M., Dossey L., Cullen L.M., et al. Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer. BMC Cancer 2009, 9:374.
45. Lanza G., Ferracin M., Gafa R., et al. mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer. Mol Cancer 2007, 6:54.
46. Volinia S., Calin G.A., Liu C.G., et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006, 103:2257-2261.
47. Bandres E., Cubedo E., Agirre X., et al. Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 2006, 5:29.
48. Sarver A.L., Li L., Subramanian S. MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration. Cancer Res 2010, 70:9570-9580.